R. Parkman

发表

Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.

N. Kapoor, R. O'reilly, J. Rappeport, 2011, Hematology/oncology clinics of North America.

Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.

N. Kapoor, R. O'reilly, J. Rappeport, 2010, Immunology and allergy clinics of North America.

Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).

K. Weinberg, M. Hershfield, D. Kohn, 2005, Clinical immunology.

GENE THERAPY FOR T-CELL IMMUNODEFICIENCIES

K. Weinberg, D. Kohn, R. Parkman, 2000, Radiologic Clinics of North America.

Gene Therapy with Cord Blood Hematopoietic Stem Cells for Adenosine Deaminase Deficiency: An Update

K. Weinberg, D. Kohn, J. Nolta, 2000 .

Clinical Protocol Amendment to Clinical Research Project Project 90-C-195

D. Kohn, C. Dunbar, W. Ramsey, 1999 .

Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.

W. Anderson, M. Clerici, K. Weinberg, 1999, Human gene therapy.

T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates

K. Weinberg, L. Barsky, G. Crooks, 1998, Nature Medicine.

Gene therapy for newborns

D. Kohn, R. Parkman, 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Gene therapy in the United States: a five-year status report.

A. Motulsky, R. Erickson, S. Straus, 1996, Human gene therapy.

T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.

K. Weinberg, D. Kohn, L. Sender, 1993, The Journal of clinical investigation.

Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

K. Weinberg, G. Crooks, D. Kohn, 1995, Nature Medicine.

Progressive Declines in Neurocognitive Function Among Survivors of Hematopoietic Stem Cell Transplantation for Pediatric Hematologic Malignancies

K. Weinberg, G. Crooks, D. Kohn, 2008, Journal of pediatric hematology/oncology.

Busulfan and Cyclophosphamide as a Conditioning Regimen for Pediatric Acute Lymphoblastic Leukemia Patients Undergoing Bone Marrow Transplantation

K. Weinberg, G. Crooks, D. Kohn, 2004, Journal of pediatric hematology/oncology.

Second hematopoietic stem cell transplantation in pediatric patients: overall survival and long-term follow-up.

K. Weinberg, G. Crooks, D. Kohn, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sequential hematopoietic stem cell and kidney transplantation in schimke immuno-osseous dysplasia: towards a model for establishing functional immune tolerance for solid organ transplantation

K. Weinberg, M. Roncarolo, P. Grimm, 2021 .

Anti-CD52 Antibody-Mediated Immune Ablation with Autologous Immune Recovery for the Treatment of Refractory Juvenile Polymyositis

K. Weinberg, A. Reiff, G. Crooks, 2011, Journal of Clinical Immunology.

Discontinuous density gradient analysis of human bone marrow: presence of alloantigen--responsive, PHA--unresponsive cells in norman bone marrow; absence of B lymphocytes in the bone marrow of patients with X--linked agammaglobulinemia.

R. Geha, F. Rosen, J. Gatien, 1974, Clinical immunology and immunopathology.

Bone Marrow Transplantation for NonMalignant Disease

K. Sullivan, R. Parkman, M. Walters, 2000 .

Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes.

J. Lipton, D. Nathan, B. Smith, 1985, Blood.

Chapter 55 – Primary Immunodeficiencies

R. Parkman, 2005 .

Primary Immune Deficiency Treatment Consortium (PIDTC) report.

M. van der Burg, L. Notarangelo, H. Bobby Gaspar, 2014, The Journal of allergy and clinical immunology.

SURFACE PROTEIN ABNORMALITIES IN LYMPHOCYTES AND PLATELETS FROM PATIENTS WITH WISKOTT-ALDRICH SYNDROME

S. Perrine, R. Parkman, E. Remold-O’Donnell, 1981, The Lancet.

Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome

R. Parkman, E. Remold-O’Donnell, F. Rosen, 1984, The Journal of experimental medicine.

Patients beware: commercialized stem cell treatments on the web.

Patrick L. Taylor, I. Weissman, R. Barker, 2010, Cell stem cell.

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells

R. de Waal Malefyt, J. Abrams, J. D. de Vries, 1994, The Journal of experimental medicine.

Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome

K. Weinberg, M. Fukuda, F. Le Deist, 1991, The Journal of experimental medicine.

Histiocytosis-X: Demonstration of Abnormal Immunity, T-Cell Histamine H2-Receptor Deficiency, and Successful Treatment with Thymic Extract

P. Lavin, G. Vawter, J. Greenberger, 1981 .

Aberrations of suppressor T cells in human graft-versus-host disease.

E. Reinherz, F. Rosen, S. Schlossman, 1979, The New England journal of medicine.

Immunologic detection of intracellular and cell-surface lysozyme with human and experimental leukemic leukocytes.

D. Rosenthal, J. Greenberger, A. Karpas, 1977, Clinical Immunology and Immunopathology.

Graft-Versus-Host Reaction

R. Parkman, 1998 .

The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants.

K. Weinberg, G. Crooks, D. Kohn, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation for metabolic diseases.

K. Weinberg, G. Crooks, D. Kohn, 1996, Cancer treatment and research.

Bone marrow transplantation for immunodeficiency and genetic diseases.

D. Kohn, R. Parkman, C. Lenarsky, 1990, Cancer treatment and research.

Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.

K. Weinberg, R. Parkman, Kenneth I. Weinberg, 1990, The New England journal of medicine.

Abelson virus-transformed lymphocytes: Null cells that modulate H-2

J. Strominger, N. Rosenberg, R. Parkman, 1977, Cell.

Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients.

D. Nathan, B. Camitta, J. Rappeport, 1978, Blood.

The control of autoreactivity. I. Lack of autoreactivity in murine spleens is due to concomitant presence of suppressor and autocytotoxic lymphocytes.

R. Parkman, M. Osband, 1978, Journal of immunology.

Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow.

K. Weinberg, J. D. de Vries, M. Roncarolo, 1995, Blood.

The application of bone marrow transplantation to the treatment of genetic diseases.

R. Parkman, 1986, Science.

Mycobacterium avium-intracellulare infections after allogeneic bone marrow transplantation in children.

K. Weinberg, D. Kohn, R. Parkman, 1990, The American journal of pediatric hematology/oncology.

Terminal deoxynucleotidyl transferase in normal and neoplastic hematopoietic cells.

D. Baltimore, R. Mccaffrey, R. Parkman, 1976, Hamatologie und Bluttransfusion.

Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes.

D. Baltimore, R. Mccaffrey, R. Parkman, 1975, The New England journal of medicine.

Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.

J. Belli, R. Geha, F. Rosen, 1978, The New England journal of medicine.

Human graft-versus-host disease.

R. Parkman, Robertson Parkman, 1980, Immunodeficiency reviews.

Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens.

M. Bevan, R. Parkman, B. Hamilton, 1981, Journal of immunology.

Study of thymic size and function in children and adolescents with treatment refractory systemic sclerosis eligible for immunoablative therapy.

K. Weinberg, P. Krogstad, R. Parkman, 2009, Clinical immunology.

Antigen-specific T-lymphocyte function after cord blood transplantation.

J. Wagner, E. Guinan, J. Kurtzberg, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pre‐ and post‐natal treatment of hemophagocytic lymphohistiocytosis

K. Weinberg, G. Crooks, D. Kohn, 2009, Pediatric blood & cancer.

A method for the preparation of mononuclear cells devoid of platelet contamination and its application to the evaluation of putative alpha-receptors in normal and asthmatic subjects.

D. Learn, R. Parkman, J. Easton, 1988, Journal of immunological methods.

Transfer factor treatment of chronic mucocutaneous candidiasis: requirement for donor reactivity to candida antigen.

J. David, R. Parkman, R. Rocklin, 1978, Clinical immunology and immunopathology.

A 2-hit model for chronic GVHD.

R. Parkman, 2013, Blood.

Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.

K. Weinberg, M. Roncarolo, P. Grimm, 2022, The New England journal of medicine.

A Patient with Post‐Hepatitis B Immune Deficiency: Nonspecific Helper Factor Partially Restores the in vitro Immune Response 1

T. Strom, M. Sheehy, E. Yunis, 1981, Vox sanguinis.

Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.

K. Mahadeo, N. Kapoor, R. Parkman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.

K. Weinberg, D. Kohn, L. Sender, 1991, Bone marrow transplantation.

Is chronic graft versus host disease an autoimmune disease?

R. Parkman, 1993, Current opinion in immunology.

Severe combined immunodeficiency and adenosine deaminase deficiency.

E. Gelfand, F. Rosen, R. Parkman, 1973, The New England journal of medicine.

Isolation on discontinuous gradients of bovine albumin of a subpopulation of human lymphocytes exhibiting precursor characteristics

J. Gatien, E. Schneeberger, R. Parkman, 1975, European journal of immunology.

Immunological reconstitution following bone marrow transplantation

K. Weinberg, R. Parkman, 1997, Immunological reviews.

Bone marrow transplantation for genetic diseases.

K. Weinberg, D. Kohn, R. Parkman, 1990, Pediatric annals.

Bone Marrow Transplantation and Intensive Care Units: A Need for Integration

R. Parkman, 1987 .

Busulfan and total body irradiation as antihematopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogenic bone marrow transplantation.

R. Geha, S. Hellman, J. Lipton, 1984, Blood.

The pathophysiology and treatment of graft-versus-host disease.

K. Sullivan, R. Parkman, 1983, Clinics in haematology.

Allogeneic bone marrow transplantation for chronic granulomatous disease.

R. Goldblum, P. Newburger, D. Nathan, 1982, The Journal of pediatrics.

Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation.

P. Newburger, M. Chusid, B. Camitta, 1980, The American journal of medicine.

Defective anticarbohydrate antibody responses to naturally occurring bacteria following bone marrow transplantation.

K. Weinberg, N. Kapoor, R. Parkman, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

K. Weinberg, G. Annett, R. Parkman, 1999, Bone Marrow Transplantation.

Aplastic anemia: lack of inhibitory effect of bone marrow lymphocytes on in vitro granulopoiesis.

P. Quesenberry, K. Zuckerman, R. Parkman, 1980, Blood.

Graft-versus-host disease: an alternative hypothesis.

R. Parkman, Robertson Parkman, 1989, Immunology today.

Regulation of human immunoglobulin E synthesis in acute graft versus host disease.

R. Geha, D. Leung, J. Rappeport, 1983, The Journal of clinical investigation.

Increased serum immunoglobulin E levels following allogeneic bone marrow transplantation.

R. Geha, F. Rosen, R. Parkman, 1980, The Journal of allergy and clinical immunology.

Antigen-Specific T Lymphocyte Function Following Cord Blood Transplantation

J. Wagner, E. Guinan, J. Kurtzberg, 2007 .

T Lymphocyte Defects

R. Parkman, 1985, Clinics in Immunology and Allergy.

SURFACE S IALOGLYCOPROTEI N T HAT IS DEFECTIVE IN WISKOTT-ALDRICH S YNDROME

R. Parkman, F. Rosen, D. Kenney, 1984 .

The biology of bone marrow transplantation for severe combined immune deficiency.

R. Parkman, 1991, Advances in immunology.

Lymphocyte phenotype does not predict immune function in pediatric patients infected with human immunodeficiency virus type 1.

J. Church, E. Gomperts, R. Parkman, 1989, The Journal of pediatrics.

COMBINATION TRANSFER FACTOR-AMPHOTERICIN B THERAPY IN A CASE OF CHRONIC MUCOCUTANEOUS CANDIDIASIS: A CONTROLLED STUDY

J. David, R. Parkman, R. Rocklin, 1976 .

Department of Health and Human Services, National Institutes of Health, Recombinant DNA Advisory Committee. Minutes of Meeting, December 1-2, 1994

R. Haselkorn, A. Motulsky, R. Samulski, 1995 .

Age, the thymus, and T lymphocytes.

K. Weinberg, R. Parkman, 1995, The New England journal of medicine.

STUDIES WITH AN ANTIBODY TO RAT LYSOZYME.

R. Parkman, A. Glynn, 1964, Immunology.

Murine Sarcoma Virus: The Question of Defectiveness

J. Levy, R. Parkman, R. Ting, 1970, Science.

Selection of patients for bone marrow transplantation in severe aplastic anemia.

D. Nathan, B. Camitta, J. Rappeport, 1975, Blood.

Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation.

D. Nathan, B. Camitta, J. Rappeport, 1974, Blood.

ACUTE GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF BONE-MARROW TRANSPLANTS FROM IDENTICAL TWIN DONORS

M. Mihm, E. Reinherz, S. Lopansri, 1979, The Lancet.

Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans

M. Levin, M. Oxman, J. Rappeport, 1978, Infection and immunity.

Correction of antigen-specific T-lymphocyte function by recombinant cytokines in children infected with human immunodeficiency virus type 1.

J. Church, K. Weinberg, E. Gomperts, 1992, The Journal of pediatrics.

Preparation for bone marrow transplantation

R. Parkman, 2005, Springer Seminars in Immunopathology.

Biosynthesis of C4 (Fourth Component of Complement) by Hybrids of C4-Deficient Guinea Pig Cells and HeLa Cells

H. Colten, R. Parkman, Harvey R. Colten, 1972, Science.

Identification of a subpopulation of lymphocytes in human peripheral blood cytotoxic to autologous fibroblasts

F. Rosen, R. Parkman, 1976, The Journal of experimental medicine.

population in children with acute lymphoblastic leukemia bone marrow progenitor - CD38 + Detection of leukemic cells in the CD34

K. Weinberg, J. Franklin, R. Parkman, 2011 .

Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.

K. Weinberg, J. Franklin, K. Kerkof, 2001, Blood.

allogenic bone marrow transplantation in the preparation of patients with congenital bone marrow disorders for Busulfan and total body irradiation as antihematopoietic stem cell agents

B. Smith, R. Geha, S. Hellman, 2013 .

Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.

R. Stern, F. Rosen, J. Nelson, 1976, The Journal of clinical investigation.

Antigen-specific immunity following hematopoietic stem cell transplantation.

R. Parkman, 2008, Blood cells, molecules & diseases.

Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.

J. Wagner, E. Guinan, J. Kurtzberg, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antigen-specific immune function after hematopoietic stem cell transplantation.

R. Parkman, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.

Aaron R Cooper, O. Yang, D. Gjertson, 2012, Blood.

Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.

F. Rosen, D. Mosier, C. Carpenter, 1974, The New England journal of medicine.

DiGeorge syndrome: still an enigma.

K. Weinberg, R. Parkman, 1998, The Journal of pediatrics.

NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation.

J. Hansen, J. Clark, M. Hertz, 1993, The American review of respiratory disease.

Efficacy of a short course (four doses) of methotrexate following bone marrow transplantation for prevention of graft-versus-host disease.

J. Lipton, D. Nathan, B. Smith, 1985, Transplantation.

Application of bone marrow transplantation in genetic diseases.

F. Rosen, B. Smith, J. Rappeport, 1983, Clinics in haematology.

Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia.

R. Storb, R. Hoffmann, R. Gale, 1983, Blood.

Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients.

F. Rosen, B. Camitta, J. Rappeport, 1978, Transplantation proceedings.

Proliferative andInterferon Responses byPeripheral Blood Mononuclear Cells After BoneMarrowTransplantation inHumans

M. Oxman, J. Rappeport, R. Parkman, 1978 .

Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection.

K. Weinberg, D. Kohn, L. Sender, 1993, The American journal of pediatric hematology/oncology.

Acute Iron Poisoning in Children: The Problem of Appropriate Therapy

D. S. Fischer, R. Parkman, D. Fischer, 1971 .

Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.

N. Jaffe, R. Parkman, H. Watts, 1977, The New England journal of medicine.

Pharmacology studies of 1-beta-D-arabinofuranosylcytosine in pediatric patients with leukemia and lymphoma after a biochemically optimal regimen of loading bolus plus continuous infusion of the drug.

K. Weinberg, T. Coates, V. Avramis, 1989, Cancer research.

Tumor hybrid cells: an immunotherapeutic agent.

R. Parkman, 1974, Journal of the National Cancer Institute.

Overview: bone marrow transplantation in the 1990s.

R. Parkman, 1994, The American journal of pediatric hematology/oncology.

In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.

J. Nolta, R. Parkman, M. Ozkaynak, 1990, Cancer research.

Current status of bone marrow transplantation in pediatric oncology

R. Parkman, 1986, Cancer.

The effect of thymic function on immunocompetence following bone marrow transplantation.

K. Weinberg, S. Forman, G. Annett, 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression.

K. Weinberg, L. Barsky, G. Crooks, 1999, Blood.

Gene therapy for adenosine deaminase deficiency.

K. Weinberg, G. Crooks, D. Kohn, 2000, Annual review of medicine.

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

J. Ritz, D. Miklos, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Umbilical cord blood cell transduction by retroviral vectors: preclinical studies to optimize gene transfer.

D. Kohn, J. Nolta, R. Parkman, 1994, Blood cells.

Bone marrow transplantation for the treatment of immune deficiency states.

R. Parkman, C. Lenarsky, 1990, Bone marrow transplantation.

T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.

K. Weinberg, G. Crooks, D. Kohn, 2000, Archivum immunologiae et therapiae experimentalis.

Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.

K. Weinberg, M. Borchert, G. Crooks, 2007, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

D. Miklos, J. Pidala, E. Russek-Cohen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.

R. Parkman, E. Remold-O’Donnell, F. Rosen, 1986, Blood.

ADENOSINE-DEAMINASE DEFICIENCY IN A CHILD DIAGNOSED PRENATALLY

N. Beratis, R. Parkman, S. Polmar, 1975, The Lancet.

AlteredO-GlycanSynthesisinLymphocytes from PatientswithWiskott-Aldrich Syndrome

M. Fukuda, R. Parkman, Enfants Malades, 1991 .

GPL-115 deficiency: a new class of immunodeficiencies.

F. Rosen, R. Parkman, E. Remold-O’Donnell, 1983, Birth defects original article series.

Bone marrow transplantation for an infant with neutrophil dysfunction.

T. Stossel, J. Cassady, D. Nathan, 1977, Experimental hematology.

Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.

R. Parkman, R. Levey, 1977, Transplantation proceedings.

The immunopathology of marrow failure.

R. Parkman, 1978, Clinics in haematology.

Immature T lymphocytes in the peripheral blood of bone marrow transplant recipients.

J. Rappeport, R. Parkman, M. Dunn, 1983, Transplantation.

K. Weinberg, D. Kohn, R. Parkman, 1993, Bone marrow transplantation.

Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.

E. Guinan, D. Nathan, B. Smith, 1985, Transplantation.

Hematopoietic stem cell transplantation for primary lymphoid immunodeficiencies.

G. Crooks, D. Kohn, N. Kapoor, 1998, Seminars in hematology.

DETECTION OF GENETICALLY DETERMINED HISTOCOMPATIBILITY ANTIGEN DIFFERENCES BETWEEN HL‐A IDENTICAL AND MLC NONREACTIVE SIBLINGS

F. Rosen, B. Camitta, J. Rappeport, 1976, Transplantation.

Immune abnormalities in patients lacking a lymphocyte surface glycoprotein.

F. Rosen, J. Rappeport, R. Parkman, 1984, Clinical immunology and immunopathology.

Molecular heterogeneity of a lymphocyte glycoprotein in immunodeficient patients.

R. Parkman, D. Reisinger, 1987, The Journal of clinical investigation.

INTERLEUKIN 2 (IL-2) RESTORATION OF DEFECTIVE IN VITRO LYMPHOCYTE PROLIFERATION FOLLOWING BONE MARROW TRANSPLANTATION (BMT)

K. Weinberg, R. Parkman, C. Lenarsky, 1987, Pediatric Research.

Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.

L. Notarangelo, J. Puck, K. Sullivan, 2008, The Journal of allergy and clinical immunology.

Cell-mediated cytotoxicity against skin fibroblasts in atopic dermatitis.

R. Geha, D. Leung, R. Parkman, 1982, Journal of immunology.

American Society for Blood and Marrow Transplantation guidelines for training.

J. Fay, E. Shpall, E. Petersdorf, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.

R. Parkman, 1986, Journal of immunology.

Severe combined immunodeficiency disease, adenosine deaminase deficiency and gene therapy.

E. Gelfand, R. Parkman, 1991, Current opinion in immunology.

Hematopoietic stem cell transplantation for severe combined immune deficiency

K. Weinberg, G. Crooks, D. Kohn, 2001, Current allergy and asthma reports.

Hla antigens and haplotypes in 200 patients with aplastic anemia.

R. Storb, E. Albert, B. Camitta, 1976, Transplantation.

Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.

P. Lavin, J. Ingelfinger, E. Yunis, 1982, Journal of immunology.

Successful Hematopoietic Stem Cell Transplantation for Niemann-Pick Disease Type B

K. Weinberg, G. Crooks, D. Kohn, 2005, Pediatrics.

Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.

K. Weinberg, D. Kohn, J. Nolta, 1990, Bone marrow transplantation.

Mixed chimerism: good news or bad news?

R. Parkman, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunological Reconstitution Following Hematopoietic Cell Transplantation

K. Weinberg, R. Parkman, 2007 .

Kinetics of the anti-recipient cytotoxic cell response of mice with minor histocompatibility antigen graft-vs-host disease.

R. Parkman, B. Hamilton, 1982, Journal of immunology.

Bone marrow transplantation for genetic diseases.

K. Weinberg, D. Kohn, R. Parkman, 1991, Hematology/oncology clinics of North America.

Long-Term Neurocognitive Function of Pediatric Patients with Severe Combined Immune Deficiency (SCID): Pre- and Post-Hematopoietic Stem Cell Transplant (HSCT)

D. Kohn, C. Azen, R. Parkman, 2008, Journal of Clinical Immunology.

Neonatal thymectomy: does it affect immune function?

W. Wells, M. Barr, R. Parkman, 1998, The Journal of thoracic and cardiovascular surgery.

Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency

I. Weissman, A. Logan, K. Weinberg, 2019, Blood.

Toxicity-Free Hematopoietic Stem Cell Engraftment Achieved with Anti-CD117 Monoclonal Antibody Conditioning

I. Weissman, A. Logan, K. Weinberg, 2019, Biology of Blood and Marrow Transplantation.

T lymphocyte abnormalities in juvenile systemic sclerosis patients.

T. Triche, K. Weinberg, A. Reiff, 2013, Clinical immunology.

Cyclosporine: GVHD and beyond.

R. Parkman, 1988, The New England journal of medicine.

GRAFT-VERSUS-HOS T DISEASE

R. Parkman, 1991 .

1522 A SUBPOPULATION OF LYMPHOCYTES IN HUMAN PERIPHERAL BLOOD quadruplicate with two fibroblast l ines as targets

F. Rosen, R. Parkman, 2003 .

The selective growth of murine newborn-derived suppressor cells and their probable mode of action.

M. Jadus, R. Parkman, 1986, Journal of immunology.

Cytokines and T lymphocytes in pediatrics.

R. Parkman, 1991, The Journal of pediatrics.

Immunologic resolution of human chronic graft-versus-host disease.

K. Mahadeo, N. Kapoor, R. Parkman, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ACUTE AND CHRONIC GRAFT‐VERSUS‐HOST DISEASE INDUCED BY MINOR HISTOCOMPATIBILITY ANTIGENS IN MICE

R. Parkman, B. Hamilton, 1983, Transplantation.

The Role of Autoreactive T Lymphocytes in Graft-versus-Host Disease (GVHD)

Y. DeClerck, R. Parkman, J. Champagne, 1988 .

Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease.

Y. DeClerck, R. Parkman, V. Draper, 1986, Journal of immunology.

Chronic graft‐versus-host disease

R. Parkman, 1998, Current opinion in hematology.

922 TREATMENT OF MURINE AND HUMAN BONE MARROW WITH MONO-CLONAL ANTIBODIES TO T LYMPHOCYTES TO PREVENT GRAFT VERSUS HOST DISEASE (GVHD)

J. Lipton, R. Parkman, B. Hamilton, 1981, Pediatric Research.

Morphology and lytic mechanisms of interleukin 3-dependent natural cytotoxic cells: tumor necrosis factor as a possible mediator.

J. Djeu, G. Schmunk, M. Jadus, 1986, Journal of immunology.